A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS). [electronic resource]
Producer: 20201021Description: 7390 p. digitalISSN:- 2045-2322
- Adult
- Aged
- Aurora Kinase A -- antagonists & inhibitors
- Biomarkers, Tumor -- genetics
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Hypertension -- chemically induced
- Male
- Middle Aged
- Mutation
- Neoplasm Grading
- Progression-Free Survival
- Protein Kinase Inhibitors -- administration & dosage
- Pyrazoles -- administration & dosage
- Pyrimidines -- administration & dosage
- Receptor-Like Protein Tyrosine Phosphatases, Class 3 -- genetics
- Sarcoma -- drug therapy
- Exome Sequencing
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.